CLINICAL IMPACT OF METRONOMIC ORAL COMBINATION CHEMOTHERAPY WITH CAPECITABINE AND CYCLOPHOSPHAMIDE IN PATIENTS WITH METASTATIC BREAST CANCER

被引：0
|
作者：
Fujihara, Miwa [1 ]
Ohtani, Shoichiro [1 ]
Ito, Mistuya [1 ]
Kajiwara, Yukiko [1 ]
Yoshimura, Yuri [1 ]
机构：
[1] Hiroshima City Hiroshima Citizens Hosp, Breast Surg, Naka Ku, Hiroshima, Japan
来源：
BREAST | 2015年 / 24卷
关键词：
D O I：
10.1016/S0960-9776(15)30065-5
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
PO53
引用
收藏
页码：S40 / S40
页数：1
相关论文
共 50 条
  • [31] Metronomic chemotherapy in metastatic breast cancer: Impact on VEGF
    El-Arab, Lobna R. Ezz
    Swellam, Menha
    El Mahdy, Manal M.
    JOURNAL OF THE EGYPTIAN NATIONAL CANCER INSTITUTE, 2012, 24 (01) : 15 - 22
  • [32] Metronomic chemotherapy with capecitabine for metastatic colorectal cancer in very elderly patients
    Jung, Yun Hwa
    Lee, Won Jik
    Byeon, Jae Ho
    Lee, In Kyu
    Han, Chi Wha
    Woo, In Sook
    KOREAN JOURNAL OF INTERNAL MEDICINE, 2017, 32 (05): : 926 - 929
  • [33] A phase I trial of oral metronomic vinorelbine plus capecitabine in patients with metastatic breast cancer
    Saridaki, Zacharenia
    Malamos, Nikolaos
    Kourakos, Panagiotis
    Polyzos, Aristides
    Ardavanis, Alexandros
    Androulakis, Nikolaos
    Kalbakis, Kostas
    Vamvakas, Lambros
    Georgoulias, Vassilis
    Mavroudis, Dimitris
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2012, 69 (01) : 35 - 42
  • [34] A phase I trial of oral metronomic vinorelbine plus capecitabine in patients with metastatic breast cancer
    Zacharenia Saridaki
    Nikolaos Malamos
    Panagiotis Kourakos
    Aristides Polyzos
    Alexandros Ardavanis
    Nikolaos Androulakis
    Kostas Kalbakis
    Lambros Vamvakas
    Vassilis Georgoulias
    Dimitris Mavroudis
    Cancer Chemotherapy and Pharmacology, 2012, 69 : 35 - 42
  • [35] Macrocytosis predicts response to metronomic chemotherapy with capecitabine and cyclophosphamide in combination with bevacizumab
    Dellapasqua, S.
    Bagnardi, V.
    Bertolini, F.
    Sandri, M. T.
    Pastrello, D.
    Cancello, G.
    Montagna, E.
    Goldhirsch, A.
    Colleoni, M.
    BREAST, 2011, 20 : S41 - S42
  • [36] A phase I study of oral metronomic vinorelbine plus capecitabine in patients with metastatic breast cancer
    Kalykaki, A.
    Agelaki, S.
    Kotsakis, A.
    Vamvakas, L.
    Bozionelou, V.
    Kalbakis, K.
    Androulakis, N.
    Georgoulias, V.
    Mavroudis, D.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [37] Capecitabine maintenance therapy after docetaxel/capecitabine combination chemotherapy in patients with metastatic breast cancer
    Gursoy, Pinar
    Surmeli, Zeki Gokhan
    Cakar, Burcu
    Arslan, Cagatay
    Zengel, Baha
    Karaca, Burcak
    Sezgin, Canfeza
    Karabulut, Bulent
    Sanli, Ulus Ali
    Uslu, Ruchan
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [38] Highly efficacious nontoxic preclinical treatment for advanced metastatic breast cancer using combination oral UFT-cyclophosphamide metronomic chemotherapy
    Munoz, R
    Man, S
    Shaked, Y
    Lee, CR
    Wong, J
    Francia, G
    Kerbel, RS
    CANCER RESEARCH, 2006, 66 (07) : 3386 - 3391
  • [39] Capecitabine (X) in combination with Cyclophosphamide (C) and Methotrexate (M) for patients with metastatic breast cancer
    Mariani, Gabriella
    Petrelli, Fausto
    Zambetti, Milvia
    Moliterni, Angela
    Valagussa, Pinuccia
    Marchiano, Alfonso
    Gianni, Luca
    ANNALS OF ONCOLOGY, 2004, 15 : 28 - 29
  • [40] Metronomic cyclophosphamide-etoposide chemotherapy and serum VEGF level in metastatic breast cancer patients
    Artac, Mehmet
    Bozcuk, Hakan
    Afacan, Berna
    Ozdogan, Mustafa
    Timur, Mujgan
    Yildiz, Mustafa
    Samur, Mustafa
    Savas, Burhan
    ANNALS OF ONCOLOGY, 2006, 17 : 86 - 87
12345